Quince Therapeutics, Inc. (QNCX)
Market Open
11 Aug, 16:17
NASDAQ (NGS) NASDAQ (NGS) Primary $
31. 62
+0.98
+3.1811%
$
8.41M Market Cap
- P/E Ratio
- Div Yield
10,819 Volume
0 Eps
$ 30.65
Previous Close 
Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. (QNCX) Statistics
Valuation metrics
Market Cap 8.41M
Enterprise value -9.35M
Trailing P/E (ttm) -0.24
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 0.48
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.73
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 44.28K
Average volume (90 days) 1.15M
Price summary
52-Week low 15.1
52-Week high 910
Beta -
50-Day moving average 22.2
200-Day moving average 5.45
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 30 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.24%
Return on equity 18.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -131.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 72.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 2.92%
Book value per share (mrq) 62.57
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
